BillionToOne

Assistant Controller

Remote

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Medical Devices, HealthcareIndustries

Requirements

The Assistant Controller requires a Bachelor's degree in Accounting or Finance, and a minimum of 5 years of experience in a similar role, with demonstrated expertise in financial reporting, inventory accounting, and cost accounting. Strong knowledge of US GAAP and experience with complex accounting systems are essential, along with a proven ability to manage and oversee accounting functions and processes.

Responsibilities

The Assistant Controller will oversee monthly, quarterly, and annual financial reporting, ensuring timely and effective processes and controls in reporting the company's financial position and cash flows, and will manage inventory and cost accounting, partnering with Supply Chain to improve processes and ensure accurate financial reporting. They will also oversee equity and tax accounting processes and procedures, contributing to the overall financial health and transparency of BillionToOne.

Skills

Molecular Diagnostics
Molecular Counting Technology
Diagnostic Test Development
Prenatal Screening
Liquid Biopsy
Fetal Risk Assessment
Oncology Diagnostics
Product Development
Biotechnology
Laboratory Operations

BillionToOne

Molecular diagnostics for prenatal and oncology testing

About BillionToOne

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy, efficiency, and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to positively impact healthcare by making molecular testing more reliable and available to everyone.

Key Metrics

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$380.2MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Competitive pay
Retirement savings package
Parental leave
Free snacks & lunches
Medical, dental, & vision premiums
On campus perks
Free-on-site EV charging

Risks

Emerging biotech startups could threaten BillionToOne's market share.
Rapid technological advancements may render their current technology obsolete.
Expansion into new facilities may face operational challenges or delays.

Differentiation

BillionToOne's QCT technology detects DNA variations at single base-pair resolution.
Their UNITY Fetal Antigen NIPT is the first US cfDNA test for fetal antigen genotyping.
They replace invasive amniocentesis with a safe, affordable blood test for prenatal screening.

Upsides

BillionToOne achieved a billion-dollar valuation with a $130 million funding round.
Their new Austin facility will create 1,000 jobs, boosting production and local economy.
Recognition as Diagnostics Company of the Year highlights their industry leadership.

Land your dream remote job 3x faster with AI